Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 713-719

  Tiwari, R K ^a   Geliebter, J ^a   Garikapaty, V P S ^a   Yedavelli, S P K ^a   Chen, S ^a   Mittelman, A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anti tumor effects; PC SPES; Pulmonary metastases; Rat model; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; HERBAL PREPARATION PC SPES; HERBAL PREPARATION PC-SPES; PLANT EXTRACT;

ANIMAL; ARTICLE; BODY WEIGHT; CANCER TRANSPLANTATION; CELL DIVISION; DRUG EFFECT; LUNG TUMOR; MALE; METASTASIS; PATHOLOGY; PHYTOTHERAPY; PROSTATE TUMOR; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BODY WEIGHT; CELL DIVISION; DRUGS, CHINESE HERBAL; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; RATS;

EID: 0033111942     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.713     Document Type: Article

References (27)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics. Cancer J Clin 48: 6-29, 1998.
2. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. Cancer J Clin 46: 5-27, 1996.
3. Scher SL: Prostate cancer: improving the therapeutic index. Semin Oncol 21: 688-693, 1994.
4. Visakorpi T, Hyytinen E, Koivisto P, et al: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401-407, 1995.
5. Scher HI, Zhang ZF and Kelly WK: Hormone and antihormone withdrawal therapy: implication for management of androgen independent prostate cancer. Urology 47: 61-69, 1996.
6. Steiner MS: Role of peptide growth factors in the prostate: a review. Urology 42: 99-110, 1993.
7. Peehl DM, Wong ST and Stamey TA: Cytostatic effects of suramin on prostate cancer cells cultured from primary tumors. J Urol 145: 624-630, 1991.
8. Eisenberger MA, Sinibaldi VJ, Reyno LM, et al: Phase I clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone refractory prostate cancer. J Clin Oncol 13: 2174-2186, 1995.
9. Fan S and Wang X: Composition of herbal extracts. SPES, United States patent number 5,417979, issued May 1995.
10. Fan S and Wang X: Herbal composition for treating prostate cancer. PC-SPES, pending United States patent number 08/697920.
11. Halicke DH, Ardel B, Juan G, Mittelman A, Chen S, Traganos F and Darzynkicwicz Z: Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparations PCSPES. Int J Oncol 11: 437-448, 1997.
12. Murasugi A, Taneka S, Komiyama N, Iwata N, Kino K, Tsumo H and Sakuna S: Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein ling zhi-8 from a fungus Ganoderma lucidum. J Biol Chem 266: 2486-2493, 1991.
13. Hung HL, Wang HL and Hseih LM: Antiproliferative effect of baicalein, a flavonoid from a Chinese herb on vascular smooth muscle. Eur J Pharmacol 251: 91-93, 1994.
14. Iehle C, Delos S, Guitou O, Tate R, Raynaud JP and Martin PM: Human prostatic steroid 5α reductase isoforms - a comparative study of selective inhibitors. J Steroid Biochem Mol Biol 54: 273-279, 1995.
15. Liu J, Wang S, Liu H and Yang LNG: Stimulatory effect of saponin from Panax ginseng on immune function of lymphocytes in the elderly. Mech Ageing Dev 83: 43-53, 1995.
16. Mizuno M, Yamada J, Teri H, Kozukue N, Lee YS and Tsuchida H: Differences in immunoblotting effects between wild and cultured Panax ginseng. Biochem Beefiest Res Common 200: 1672-1678, 1994.
17. Stencil DM and Clarke CH: Specificity of antimutagens against chemical mutagens in microbial systems. Basic Life Sci 52: 457-460, 1990.
18. Zani F, Cuzzoni MT, Daglia M, Benvenuti S, Vampa G and Mazza P: Inhibition of mutagenicity in Salmonella typhimurium by Glycrrhiza galbra extract glycrrhizinic and 18α and 18ß glycerrhetinic acids. Planta Med 59: 502-507, 1993.
19. Isaacs JT, Isaacs WB, Feitz WFJ and Scheres J: Establishment and characterization of seven Dunning rat prostate cancer cell lines and their use in developing methods for predicting metastatic abilities of prostate cancer. Prostate 9: 261-281, 1986.
20. Chen X and Han R: Effect of glycyrrhetinic acid on DNA damage and unscheduled DNA synthesis induced by benzo(α)pyrene. Chin Med Sci J 10: 16-19, 1995.
21. Delos S, Carsol JL, Ghazarossian E, Raynaud J and Martin PM: Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J Steroid Biochem Mol Biol 55: 375-383, 1995.
22. Carilla E, Briley M, Fauran F, Sultan C and Duvillius C: Binding of permixon, a new treatment for prostatic benign hyperplasia to the cytostatic androgen receptor in the rat prostate. J Steroid Biochem 20: 521-523, 1984.
23. Austin CA, Patel S, Ono K, Nakane H and Fisher LM: Site specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 282: 883-889, 1992.
24. Matsuzaki Y, Kuokawa N, Terai S, Matsumura Y, Kobayashi N and Okita K: Cell death induced by baicalcin in human hepatoccllular carcinoma cell lines. Jpn J Cancer Res 87: 170-177, 1996.
25. Huan KC: The Pharmacology of Chinese Herbs. CRC Press, 1993.
26. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawa S, Momosaki S and Kojiro M: The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 54: 448-454, 1994.
27. Di Paola RS, Zhang H, Lambert GH, Meeker R, et al: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339: 785-791, 1998.